SCHEMBL2606341

SCHEMBL2606341

NC(=O)N(C1CCCCC1)C1CCN(C(=O)c2ccncc2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.53
▸ POLB P06746 2/20 0.49
▸ TSHR P16473 2/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ L3MBTL3 Q96JM7 8/20 0.49
▸ GAA P10253 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.45
▸ MBTD1 Q05BQ5 5/20 0.44
▸ L3MBTL1 Q9Y468 4/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ USP2 O75604 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ SLC9A1 P19634 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606456 0.85 KDM4E (0.58) KDM4EPOLBALDH1A1L3MBTL3GAA
SCHEMBL2606351 0.82 HPGD (0.58) POLBALDH1A1L3MBTL3GAALMNA
SCHEMBL4196427 0.81 ACHE (0.59) KDM4EL3MBTL3L3MBTL1MEN1KMT2A
SCHEMBL13716161 0.77 L3MBTL3 (0.62) KDM4EPOLBTSHRALDH1A1L3MBTL3
SCHEMBL4703216 0.75 GAA (0.68) KDM4EPOLBALDH1A1GAARECQL
SCHEMBL4703332 0.75 KDM4E (0.57) KDM4EPOLBTSHRL3MBTL3GAA
SCHEMBL6045903 0.74 HPGD (0.76) KDM4ETSHRMAPK1ALDH1A1RECQL
SCHEMBL999166 0.74 KDM4E (0.41) KDM4EMAPK1
SCHEMBL2606376 0.73 C3AR1 (0.49) KDM4EALDH1A1MEN1KMT2A
SCHEMBL2606343 0.73 HTT (0.48) MAPK1ALDH1A1TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444397-A1 Heteroaryl-ureas and their use as glucokinase activators Novo Nordisk A/S (DK) 2012-04-25 — — EP disclosed
Send feedback